Watchdog Urges FDA To Put 'Black Box' Warning On Plavix

Law360, New York (August 21, 2013, 4:30 PM EDT) -- The consumer group Public Citizen pushed the U.S. Food and Drug Administration on Wednesday to warn that stent implant recipients can suffer fatal bleeding if they take the Bristol-Myers Squibb Co. and Sanofi SA blood-thinning drug Plavix for more than a year.

The FDA should put its most dire warning for a drug, a so-called black box warning, on labeling for brand-name and generic versions of Plavix to alert physicians and patients to the bleeding risk, Public Citizen said in a petition to the agency. Doctors...
To view the full article, register now.